Lisata Therapeutics Inc. Capital Reinvestment Ratio

Latest as of June 2020: 0.00x

Lisata Therapeutics Inc. capital reinvestment ratio. Lisata Therapeutics Inc. (LSTA) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow ($4.50 Million) in capital expenditures ($12.00K). Check how aggressively does Lisata Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.50 Million
USD

Capital Expenditures

$12.00K
USD

Data as of

Jun 2020
Most recent filing

Capital Reinvestment Ratio of Lisata Therapeutics Inc. (1992–2002)

Capital reinvestment ratio of Lisata Therapeutics Inc. from 1992 to 2002. This chart tracks Lisata Therapeutics Inc.'s Capital Reinvestment Ratio across 3 annual periods. Also explore Lisata Therapeutics Inc. annual equity growth to track the company's year-over-year net asset growth rate.

Lisata Therapeutics Inc. Capital Reinvestment Ratio by Year (1992–2002)

Lisata Therapeutics Inc. capital reinvestment ratio by year from 1992 to 2002. For the full cash flow conversion analysis, see cash efficiency ratio of Lisata Therapeutics Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2002 0.00x $1.01 Million $1.13K ▼ -99.9%
1993 1.06x $470.00K $500.00K ▲ +219.1%
1992 0.33x $240.00K $80.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow